Historically, optic nerve involvement has been excluded from MS diagnostic criteria, but its inclusion in the new iteration ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

Hirayama and Suzuki [13] examined the histological findings of 450 cases of nevus of Ota and classified the condition according to the distribution of the dermal melanocytes as follows ...

Semaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and obesity. Also known as GLP-1 agonists, these drugs work by mimicking a ...

Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.